Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds

Experimental Dermatology

Volumn 9, Issue 4, 2000, Pages 258-265

  Huttunen, M ^a   Aalto, M L ^a   Harvima, R J ^a   Horsmanheimo, M ^a   Harvima, I T ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chymase; Immunohistochemistry; Mast cell; Tryptase; Wound healing

Indexed keywords

CHYMASE; PROTEINASE; TRYPTASE;

ADULT; AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIZATION; HUMAN; IMMUNOCHEMISTRY; LEG ULCER; MAST CELL; WOUND; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CHRONIC DISEASE; CHYMASES; EPITHELIUM; HUMANS; MAST CELLS; MIDDLE AGED; SERINE ENDOPEPTIDASES; SKIN; TRYPTASES; VARICOSE ULCER; WOUND HEALING;

EID: 0033909721     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009004258.x     Document Type: Article

References (47)

1. Eady R A J, Cowen T, Marshall T F. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 1979: 100: 623-633.
2. Green R, Cordero A, Winkelmann R K. Epidermal mast cells. Arch Dermatol 1977: 113: 166-169.
3. Harvima I T, Naukkarinen A, Paukkonen K et al. Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993: 285: 184-192.
4. Bolton L L, Montagna W. Mast cells in human ulcers. Am J Dermatopathol 1993: 15: 133-138.
5. Harvima I T, Naukkarinen A, Harvima R J, Aalto M L, Neittaanmäki H, Horsmanheimo M. Quantitative enzymehistochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 1990: 282: 428-433.
6. Artuc M, Hermes B, Steckelings U M, Grutzkau A, Henz B M. Mast cells and their mediators in cutaneous wound healing - active participants or innocent bystanders? Exp Dermatol 1999: 8: 1-16.
7. KleinJan A, Godthelp T, Blom H M, Fokkens W J. Fixation with Carnoy's fluid reduces the number of chymase-positive mast cells: not all chymase-positive mast cells are also positive for tryptase. Allergy 1996: 51: 614-620.
8. Li L, Krilis S A. Conditioned media obtained from a human mastocytosis cell strain induce mast cells expressing chymase but not tryptase from human progenitors. Int Arch Allergy Immunol 1997: 113: 289-290.
9. Gruber B L. Mast cells: accessory cells which potentiate fibrosis. Intern Rev Immunol 1995: 12: 259-279.
10. Dayton E T, Caulfield J P, Hein A, Austen K F, Stevens R L. Regulation of the growth rate of mouse fibroblasts by IE-3-activated mouse bone marrow-derived mast cells. J Immunol 1989: 142: 4307-4313.
11. Russel J D, Russell S B, Trupin K M. The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol 1977: 93: 389-393.
12. Hatamochi A, Ueki H, Mauch C, Krieg T. Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts. J Dermatol Sci 1991: 2: 407-412.
13. Ruoss S J, Hartmann T, Caughey G H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991: 88: 493-499.
14. Forsberg-Nilsson K, Dunder U, Nilsson K, Schwartz L B, Nilsson G. The fibroblast mitogenic activity released from human basophilic cell line KU812 is separate from tryptase and PDGF expression. Scand J Immunol 1996: 44: 267-272.
15. Algermissen B, Hermes B, Feldmann-Boeddeker I, Bauer F, Henz B M. Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol 1999: 8: 193-198.
16. Gillery P, Fertin C, Nicolas J F et al. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. FEBS Lett 1992: 302: 231-234.
17. Sugarman B J, Aggarwal B B, Hass P E, Figari I S, Palladino M A Jr, Shepard H M. Recombinant human tumor necrosis factor alpha: Effects on proliferation of normal and transformed cells in vitro. Science 1985: 230: 943-945.
18. Solis-Herruzo J A, Brenner D A, Chojkier M. Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 1988: 263: 5841-5845.
19. Grutzkau A, Kruger-Krasagakes S, Baumeister H et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998: 9: 875-884.
20. Azizkhan R G, Azizkhan J C, Zetter B R, Folkman J. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1980: 152: 931-944.
21. Thornton S C, Mueller S N, Levine E M. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983: 222: 623-625.
22. Marks R M, Roche W R, Czerniecki M, Penny R, Nelson D S. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986: 55: 289-294.
23. Leibovich S J, Polverini P J, Shepard H M, Wiseman D M, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987: 329: 630-632.
24. Blair R J, Meng H, Marchese M J et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997: 99: 2691-2700.
25. Wichmann B E. The mast cell count during the process of wound healing. Acta Pathol Microbiol Scand 1955: S108.
26. Persinger M A, Lepage P, Simard J P, Parker G H. Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 1983: 108: 179-187.
27. Reich J D, Cazzaniga A L, Mertz P M, Kerdel F A, Eaglstein W H. The effect of electrical stimulation on the number of mast cells in healing wounds. J Am Acad Dermatol 1991: 25: 40-46.
28. Harper R A, Flaxman B A. Effect of pharmacologic agents on human keratinocyte mitosis in vitro. III. Inhibition by histamine and methylated analogs. J Invest Dermatol 1975: 65: 400-403.
29. Cook P W, Pittelkow M R, Shipley G D. Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors. J Cell Physiol 1991: 146: 277-289.
30. Pillai S, Bikle D D, Eessalu T E, Aggarwal B B, Elias P M. Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest 1989: 83: 816-821.
31. Horsmanheimo L, Harvima I T, Järvikallio A, Harvima R J, Naukkarinen A, Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994: 131: 348-353.
32. Ackermann L, Harvima I T. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 1998: 290: 353-359.
33. Nishikori Y, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H, Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch Dermatol Res 1998: 290: 553-560.
34. Järvikallio A, Naukkarinen A, Harvima I T, Aalto M L, Horsmanheimo M. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997: 136: 871-877.
35. Kaminska R, Harvima I T, Naukkarinen A, Nilsson G, Horsmanheimo M. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection. J Pathol 1996: 180: 434-440.
36. Kankkunen J P, Harvima I T, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997: 72: 385-388.
37. Harvima I T, Haapanen L, Ackermann L, Naukkarinen A, Harvima R J, Horsmanheimo M. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions. Acta Derm Venereol 1999: 79: 98-104.
38. Lohi J, Harvima I, Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 1992: 50: 337-349.
39. Briggaman R A, Schechter N M, Fräki J, Lazarus G S. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorpho-nuclear leukocytes. J Exp Med 1984: 160: 1027-1042.
40. Schirren C G, Scharffetter K, Hein R, Braun-Falco O, Krieg T. Tumor necrosis factor alpha induces invasiveness of human skin fibroblasts in vitro. J Invest Dermatol 1990: 94: 706-710.
41. Buck M, Houglum K, Chojkier M. Tumor necrosis factor-alpha inhibits collagen alpha1 (I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996: 149: 195-204.
42. Salomon G D, Kasid A, Cromack D T et al. The local effects of cachectin/tumor necrosis factor on wound healing. Ann Surg 1991: 214: 175-180.
43. Fu X, Tian H, Hsu S, Wang D, Sheng Z. In vivo effects of tumor necrosis factor-alpha on incised wound and gunshot wound healing. J Trauma 1996: 40: S140-S143.
44. van-Overveld F J, Jorens P G, Rampart M, de-Backer W, Vermeire P A. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991: 21: 711-714.
45. Postlethwaite A E, Holness M A, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992: 90: 1479-1485.
46. Molino M, Barnathan E S, Numerof R et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997: 272: 4043-4049.
47. Hamann K, Haas N, Grabbe J, Czarnetzki B M. Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995: 133: 203-208.